Skip to main content

Table 3 Obstetrical outcomes on follow up in subjects according to application of PBO

From: Efficacy and safety of prophylactic balloon occlusion in the management of placenta accreta spectrum disorder: a retrospective cohort study

Variable

PBO group (N = 44)

Control group (N = 219)

P-value

Menstruation renewal, Months

4 (3–6)

3 (3–5)

0.294

Hypomenorrhea

4 (9.1%)

11 (5.0%)

0.288

Menstrual disorders

7 (15.9%)

19 (8.6%)

0.165

Cesarean scar diverticulum

3 (6.8%)

5 (2.3%)

0.133

Intrauterine adhesion

2 (4.5%)

3 (1.4%)

0.196

  1. Note: The data were shown as median (interquartile range) or number (%)